Clinical Trials Directory

Trials / Completed

CompletedNCT01655043

Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRI

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
19 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Coronary artery disease (CAD, coronary heart disease) is the leading cause of death in the U.S., causing 1 in 5 deaths in 2005. The current method for diagnosing coronary artery disease that is considered most accurate is coronary angiography however it involves risk and radiation. Alternatively nuclear imaging test and MRI stress test only permits the semi qualitative analysis of the myocardial perfusion images. In this proposal the investigators will develop a means to calculate Coronary Flow Reserve (CFR) using the MRI. the investigators approach has the potential to reduce mortality from myocardial infarction by effecting a change in the patient management paradigm. Absolute quantification of myocardial perfusion will detect coronary stenosis and CAD in patients with more accuracy than the semi-quantitative or qualitative analysis of perfusion images. Measurement of Coronary Flow Reserve is important for the following reasons: decrease of coronary flow reserve has been identified as a first effect of CAD; it provides an objective measure of treatment efficacy. The purpose of this study is to compare images from nuclear stress test and/or coronary angiography with Magnetic Resonance Imaging (MRI) that will evaluate subjects with coronary artery disease calculating myocardial blood flow using a novel MRI technique combined to an extracellular Gadolinium-based contrast agent and stressor agent

Detailed description

The main hypothesis the investigators will test is that changes in myocardial blood volume, under physiologic stress, correlate with myocardial flow reserve as measured in low spatial resolution nuclear SPECT scans. Secondary hypothesis is that stress perfusion as quantified with bolus height corrected gadofosveset trisodium images, better correlate with SPECT perfusion than uncorrected, relative perfusion values. The investigators propose implementing the scan protocol using a 1.5T or 3.0T MRI scanner. The investigators will scan a series of 20 patients recruited from the nuclear stress lab at Northwestern Memorial Hospital. These subjects will be approached and enrolled into a HIPPA Compliant, IRB approved research study to assess the effectiveness of myocardial perfusion and blood volume images to measure myocardial blood volume. Subjects will be scanned with a modified version of the clinical stress-perfusion protocol. Correlation analysis will be used to test the hypothesis that quantitative blood volume is an indicator of myocardial flow reserve.

Conditions

Interventions

TypeNameDescription
DRUGRegadenosonRegadenoson will be infused intravenously 0.4 mg/5 mL (0.08 mg/mL) as a single bolus.
DRUGgadofoveset trisodiumAll subjects to receive 5 ml IV gadofoveset trisodium contrast (Ablavar) at both stress and rest.

Timeline

Start date
2012-09-01
Primary completion
2014-02-01
Completion
2014-02-01
First posted
2012-08-01
Last updated
2019-08-28
Results posted
2015-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01655043. Inclusion in this directory is not an endorsement.